Pacira Pharmaceuticals Stock Forecast

Buy or Hold candidate since Nov 10, 2025 Gain 3.51%

The Pacira Pharmaceuticals stock price gained 0.421% on the last trading day (Monday, 17th Nov 2025), rising from $23.78 to $23.88. During the last trading day the stock fluctuated 4.10% from a day low at $23.63 to a day high of $24.60. The price has risen in 6 of the last 10 days and is up by 7.62% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 270 thousand more shares were traded than the day before. In total, 732 thousand shares were bought and sold for approximately $17.49 million.

The stockhas broken the wide and falling short-term trend up. Firstly a slower falling rate is indicated, but this may very well be an early signal of a trend shift. On the reaction, there will be support on the roof of the current trend broken, which is $23.79, a level that may pose a second chance to hit a runner. According to fan-theory $27.64 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.

PCRX Signals & Forecast

The Pacira Pharmaceuticals stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $23.48 and $22.83. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, November 11, 2025, and so far it has fallen -1.00%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Pacira Pharmaceuticals stock

On the downside, the stock finds support just below today's level from accumulated volume at $22.19 and $22.05. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Pacira Pharmaceuticals finds support just below today's level at $22.19. If this is broken, then the next support from accumulated volume will be at $22.05 and $22.02.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.97 between high and low, or 4.10%. For the last week, the stock has had daily average volatility of 3.19%.

Our recommended stop-loss: $22.93 (-3.96%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 4 days ago.)

Trading Expectations (PCRX) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Pacira Pharmaceuticals to open at $24.04, and during the day (based on 14 day Average True Range), to move between $23.37 and $24.39, which gives a possible trading interval of +/-$1.03 (+/-4.39%) up or down from last closing price. If Pacira Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 4.39% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $24.12 (1.01%) than the support at $22.19 (7.08%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Pacira Pharmaceuticals stock A Buy?

Several short-term signals are positive and the break-up from the falling trend indicates a possible shift for a trend. We believe that the prices around the breaking point will indicate particularly good levels, but we also believe that the current level will hold a possible good buy level for the short-term period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

Current score: 1.172 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $24.04 ( 0.656%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk